![Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720352980-gr2.jpg)
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect
![Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720352980-gr3ac.jpg)
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect
![Baroreflex Activation Therapy for the Treatment of HFrEF – When CRT Is Not an Option | Radcliffe Cardiology Baroreflex Activation Therapy for the Treatment of HFrEF – When CRT Is Not an Option | Radcliffe Cardiology](https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6129047022001/8419144e-2ff4-4abe-acbb-584f0ea647f2/main/1280x720/5m23s157ms/match/image.jpg)
Baroreflex Activation Therapy for the Treatment of HFrEF – When CRT Is Not an Option | Radcliffe Cardiology
![Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction | Journal of the American College of Cardiology Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/3a7a0b1f-b700-47bc-8cd8-73303d762e17/fx1.jpg)
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction | Journal of the American College of Cardiology
JK Han MD on X: "𝐁𝐚𝐫𝐨𝐫𝐞𝐟𝐥𝐞𝐱 𝐀𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐢𝐧 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐚 𝐑𝐞𝐝𝐮𝐜𝐞𝐝 𝐄𝐅 (BeAT HF) in new prospective cohort: 25% ⬇️ in proBNP Significant ⬆️ in QoL &
![Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review - Molina‐Linde - 2023 - ESC Heart Failure - Wiley Online Library Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review - Molina‐Linde - 2023 - ESC Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dbc6f5e6-fe2f-411e-b500-51507006e43b/ehf214473-fig-0001-m.jpg)
Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review - Molina‐Linde - 2023 - ESC Heart Failure - Wiley Online Library
Totality of Evidence from BeAT-HF Study Shows CVRx's Barostim Provides Long-term Benefits for Patients with Heart Failure
![CVRx® Completes Enrollment of the BeAT-HF Phase III Randomized Clinical Trial, Continues to collect Morbidity and Mortality Outcomes | BioSpace CVRx® Completes Enrollment of the BeAT-HF Phase III Randomized Clinical Trial, Continues to collect Morbidity and Mortality Outcomes | BioSpace](https://mma.prnewswire.com/media/1215830/Breakthrough_device.jpg)
CVRx® Completes Enrollment of the BeAT-HF Phase III Randomized Clinical Trial, Continues to collect Morbidity and Mortality Outcomes | BioSpace
![Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial - The Lancet Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial - The Lancet](https://www.thelancet.com/cms/attachment/3bbecfcf-4284-4b43-b5c8-392594f6fd6f/gr1.gif)
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial - The Lancet
![Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure - ScienceDirect Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177921000603-fx1.jpg)
Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure - ScienceDirect
![First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF - ScienceDirect First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870318302217-gr2.jpg)
First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF - ScienceDirect
![Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720352980-fx1.jpg)